George Anastassov, the CEO of AXIM Biotech, recently spoke to us about the current good manufacturing methods (cGMPs) his company has developed, their significance to the market, and plans for the future.
The complex question of whether or not data or results are valid involves both the testing process and the actual calculated results.
I Can’t Afford Good Science: The Battle Between Economics and Method Development in the Emerging Cannabis Market
One winter afternoon, a group of professionals and scientists came together to discuss the development of test methods for cannabis.
An interview with Cynthia Ludwig
An interview with Susan Audino
An interview with Jeffrey C. Raber